EGFR and cancer: Inhibition of the receptor tyrosine kinases (RTKs) such as epidermal growth factor receptor (EGFR), ErbB2, ErbB3, vascular endothelial growth factor receptor-2 (VEGFR-2), VEGFR-3, and insulin-like growth factor 1 receptor (IGF1R) might be another molecular event associated with the antiproliferation effects of anthocyanins in cancers [92,93].